Prescription drug · ANDA
Olmesartan Medoxomil NDC 71335-2996
Olmesartan medoxomil 5 mg/1 · Tablet, Coated · Oral · Bryant Ranch Prepack
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 71335-2996-1 | 71335299601 | 90 TABLET, COATED in 1 BOTTLE (71335-2996-1)Marketed from Feb 4, 2026 | |
| 71335-2996-2 | 71335299602 | 30 TABLET, COATED in 1 BOTTLE (71335-2996-2)Marketed from Feb 4, 2026 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Olmesartan Medoxomil
- Generic name (nonproprietary)
- olmesartan medoxomil
- Active ingredients
- Olmesartan medoxomil — 5 mg/1
- Dosage form
- Tablet, Coated
- Route
- Oral
- Labeler
- Bryant Ranch Prepack
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 208659
- Marketing start
- Listing expires
- Other FDA classes
- Angiotensin 2 Receptor Antagonists (Mechanism)
- Identifiers
- Product ID 71335-2996_ad416720-0f92-4332-afcc-a65cd320781dSPL ID ad416720-0f92-4332-afcc-a65cd320781dSPL set ID 1df1ff60-6be5-4018-a28c-0d23e5867ebaRxCUI 349373UNII 6M97XTV3HD
- Pharmacologic class
- Angiotensin 2 Receptor Blocker
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N471335299601followed by a unit qualifier and the quantityPackage 71335-2996-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
Olmesartan medoxomil tablet are indicated for the treatment of hypertension, in adults and children six years of age and older, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. There are no controlled trials demonstrating risk reduction with olmesartan medoxomil. Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes …
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 208659
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Olmesartan Medoxomil | Olmesartan medoxomil 5 mg/1 | Tablet, CoatedOral | Inventia Healthcare Limited | 49252-065 |
| Olmesartan Medoxomil | Olmesartan medoxomil 20 mg/1 | Tablet, CoatedOral | Inventia Healthcare Limited | 49252-066 |
| Olmesartan Medoxomil | Olmesartan medoxomil 40 mg/1 | Tablet, CoatedOral | Inventia Healthcare Limited | 49252-067 |
| Olmesartan Medoxomil | Olmesartan medoxomil 40 mg/1 | Tablet, CoatedOral | Rising Pharma Holdings, Inc. | 64980-603 |
| Olmesartan Medoxomil | Olmesartan medoxomil 20 mg/1 | Tablet, CoatedOral | Rising Pharma Holdings, Inc. | 64980-602 |
| Olmesartan Medoxomil | Olmesartan medoxomil 5 mg/1 | Tablet, CoatedOral | Rising Pharma Holdings, Inc. | 64980-665 |